Detalhe da pesquisa
1.
In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis.
Eur J Neurol
; 31(4): e16204, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240416
2.
Hot-spot KIF5A mutations cause familial ALS.
Brain
; 141(3): 688-697, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29342275
3.
[Treatment evaluation in patients with 5q-associated spinal muscular atrophy : Real-world experience]. / Therapieevaluation bei Patienten mit 5q-assoziierter spinaler Muskelatrophie : Erfahrungen aus der klinischen Praxis.
Nervenarzt
; 90(4): 343-351, 2019 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-30617569
4.
Comprehensive analysis of the mutation spectrum in 301 German ALS families.
J Neurol Neurosurg Psychiatry
; 89(8): 817-827, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29650794
5.
Reply: Adult-onset distal spinal muscular atrophy: a new phenotype associated with KIF5A mutations.
Brain
; 142(12): e67, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31612906
6.
Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosis.
Brain Commun
; 5(3): fcad152, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37223130
7.
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
Lancet Neurol
; 17(8): 681-688, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29934198